Working… Menu
Trial record 1 of 1 for:    NCT02043288
Previous Study | Return to List | Next Study

Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02043288
Recruitment Status : Completed
First Posted : January 23, 2014
Last Update Posted : April 15, 2020
NanoCarrier Co., Ltd.
Information provided by (Responsible Party):
Orient Europharma Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2019
Actual Study Completion Date : December 2019